Skip to main content
Activeted-365133-2026

Active Ingredient Mirvetuximabum Soravtansinum for Ovarian Cancer Therapy

Seeking the supply of the active ingredient Mirvetuximabum Soravtansinum for the medication program B.50 to treat ovarian cancer. Delivery will be to the University Hospital in Szczecin.

PLN 6,466,000
View original source

CONTRACTING AUTHORITY

Name

UNIWERSYTECKI SZPITAL KLINICZNY NR 2 PUM W SZCZECINIE

City

Szczecin

Country

PL

CLASSIFICATION

Procedure Type

Open Procedure

Contract Type

Supplies

Main CPV

33652100, Antineoplastic agents.

ADDITIONAL DETAILS

EU Funded

Yes

Suitable for SMEs

Yes

Electronic Submission

Required

Legal Basis

32014L0024

DEADLINES & TIMELINE

Submission Deadline

8 days remaining

(LOT-0001)

Published

TENDER DOCUMENTS

Find matching tenders automatically

With Patterno-HIT, receive relevant tenders daily, automatically filtered to your company profile.

Book Demo Now